PCSA
NASDAQ · Pharmaceuticals
Processa Pharmaceuticals Inc
$2.77
-0.10 (-3.48%)
Open$2.95
Previous Close$2.87
Day High$2.95
Day Low$2.70
52W High$19.63
52W Low$1.76
Volume—
Avg Volume27.0K
Market Cap7.86M
P/E Ratio—
EPS$-17.05
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,232.1% upside
Current
$2.77
$2.77
Target
$36.90
$36.90
$23.79
$36.90 avg
$41.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.71M | 2.46M | 2.10M |
| Net Income | 319.8K | 302.9K | 327.4K |
| Profit Margin | 11.8% | 12.3% | 15.6% |
| EBITDA | 521.3K | 563.7K | 431.6K |
| Free Cash Flow | 364.0K | 435.1K | 285.7K |
| Rev Growth | +2.4% | +0.4% | +18.3% |
| Debt/Equity | 0.28 | 0.35 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |